Let us be your source to screen patients for the most commonly detected cancer in men in the US. We offer testing that can assist with screening, diagnosis, and management of prostate cancer.
Our Guideline-Based Hereditary Cancer Panel helps evaluate potential risk for patients to develop prostate cancer, and we offer numerous panels for diagnosis, prognosis, treatment, and monitoring.
Have your patients take the Know Your Risk Quiz: https://www.questhereditarycancer.com/patients/take-the-quiz
Quest offers a full range of Prostate Specific Antigen (PSA) testing.
Our board-certified pathologists have specialized training, are easily accessible, and provide informative reports that promote better outcomes for your patients.
Learn more at AmeriPath®: Anatomic Pathology Services
Our Prostate Triple Stain diagnostic test helps differentiate prostate cancer from precancerous lesions such as prostatic intraepithelial neoplasia (PIN), especially when tissue is limited.
PSA, Post Prostatectomy
Serial monitoring of PSA levels at regular intervals, along with physical examinations and other tests, may help to detect recurrent prostate cancer.
Find out what's happening
Quest offers its clients a dedicated oncology customer support line to assist with any test-related questions.
Contact our dedicated customer service team at: 1.833.773.1441
The Quest Hereditary Cancer Screening test portfolio offers you and your patients insights into hereditary risk so you can make more informed decisions together.